A Study of Potential Treatment-Responsive Biomarkers in Hunter Syndrome
study id #: NCT04007536
condition: Hunter Syndrome
status: Recruiting
purpose:This is an observational, Pre-phase 1 study of biomarkers in patients with mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome.
intervention: No Intervention
results: https://clinicaltrials.gov/ct2/show/results/NCT04007536
last updated: February 26, 2022
-
Daily Living With MPS and Related DiseasesDealing with your child’s diagnosis wi...
-
Mucopolysaccharidoses Fact SheetThe mucopolysaccharidoses are a group of...
-
Family Assistance ProgramProgram provides grants of up to $3000 f...
-
Molecular Analysis of Vietnamese Patients With Mucopolysaccharidosis Type IMucopolysaccharidosis type I (MPS I) is ...
-
Identification and Structure Characterization of Novel IDS Variants Causing Mucopolysaccharidosis Type II: A Retrosp...Mucopolysaccharidosis type II (MPS II) o...
-
International MPS NetworkCreated in April 1992 by Christine Laver...
-
Deep Intronic Variant in the ARSB Gene as the Genetic Cause for Maroteaux-Lamy Syndrome (MPS VI)Maroteaux-Lamy syndrome (MPS-VI) is a ra...